Form 13-F position report

MIRAGEN THERAPEUTICS INC

Reported by HighTower Advisors LLC

VRDN CUSIP 60463E103 Manager CIK 0001462245

Reported 0 shares, down 12,217 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2019
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 12 Through Q4 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for MIRAGEN THERAPEUTICS INC held by HighTower Advisors LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

35 managers reported MIRAGEN THERAPEUTICS INC for Q4 2019.

Managers reporting MIRAGEN THERAPEUTICS INC in Q4 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Atlas Venture Advisors Inc Unchanged 3,142,580 0 2.28% $1,508,000 5 qtrs
FMR LLC Unchanged 2,888,656 0 < 0.01% $1,386,000 12 qtrs
VANGUARD GROUP INC Unchanged 651,343 0 < 0.01% $312,000 12 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 464,033 +260,322 < 0.01% $223,000 5 qtrs
BlackRock Inc Reduced 415,152 -780 < 0.01% $199,000 11 qtrs
JPMorgan Chase & Co Unchanged 319,344 0 < 0.01% $153,000 10 qtrs
683 Capital Management LLC Reduced 290,000 -1,476,038 0.02% $139,000 8 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 179,901 -220,854 < 0.01% $86,000 8 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 154,719 0 < 0.01% $74,000 12 qtrs
Point72 Asset Management L P Unchanged 99,691 0 < 0.01% $48,000 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2019
Filed
February 14, 2020
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.